Emergent Biosolutions Inc (EBS)
Fair Value2.2% Upside
Fair
Analyst59.2% Upside
Market Cap390.6 M
P/E-45.2x
Yield0.0%
HealthGreat
NYSE
Featured in
High-Beta Stocks
Small-Cap Stocks
Lineage Cell Therapeutics Inc (LCTX)
Fair Value16.9% Upside
Fair
Analyst382.5% Upside
Market Cap279.2 M
P/E-4.4x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
AbbVie Inc (ABBV)
Fair Value-3.2% Downside
Fair
Analyst11.1% Upside
Market Cap430.8 B
P/E69.4x
Yield2.8%
HealthGood
NYSE
Actinium Pharmaceuticals Inc (ATNM)
Fair Value39.6% Upside
Undervalued
Analyst567.6% Upside
Market Cap25.414 M
P/E-1.0x
Yield0.0%
HealthWeak
NYSE
Armata Pharmaceuticals Inc (ARMP)
Fair Value-25.0% Downside
Overvalued
Analyst272.3% Upside
Market Cap171.8 M
P/E-0.6x
Yield0.0%
HealthWeak
NYSE
Featured in
Overvalued Stocks
CEL-SCI Corp (CVM)
Fair Value38.5% Upside
Undervalued
Analyst722.4% Upside
Market Cap23.769 M
P/E-1.0x
Yield0.0%
HealthFair
NYSE
Perspective Therapeutics Inc (CATX)
Fair Value3.4% Upside
Fair
Analyst334.9% Upside
Market Cap342.1 M
P/E-3.0x
Yield0.0%
HealthWeak
NYSE
Featured in
Small-Cap Stocks
Protalix Biotherapeutics Inc (PLX)
Fair Value-17.0% Downside
Fair
Analyst350.8% Upside
Market Cap191 M
P/E12.8x
Yield0.0%
HealthGreat
NYSE
Featured in
Overvalued Stocks
High-Beta Stocks
Theriva Biologics Inc (TOVX)
Fair Value22.0% Upside
Undervalued
Market Cap10.482 M
P/E-0.4x
Yield0.0%
HealthWeak
NYSE
Arcus Biosciences Inc (RCUS)
Fair Value-15.3% Downside
Fair
Analyst34.2% Upside
Market Cap3.622 B
P/E-9.4x
Yield0.0%
HealthFair
NYSE
Featured in
Overvalued Stocks
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
Fair Value-1.5% Downside
Fair
Analyst68.3% Upside
Market Cap2.07 B
P/E-3.2x
Yield0.0%
HealthWeak
NYSE
Featured in
High-Beta Stocks
Can Fite Biopharma Ltd ADR (CANF)
Fair Value12.6% Upside
Fair
Analyst150.0% Upside
Market Cap7.086 M
P/E-0.7x
Yield0.0%
HealthWeak
NYSE
Matinas BioPharma Holdings Inc (MTNB)
Fair Value56.2% Upside
Bargain
Market Cap1.861 M
P/E-0.2x
Yield0.0%
HealthWeak
NYSE
NanoViricides Inc (NNVC)
Fair Value-19.2% Downside
Overvalued
Analyst319.6% Upside
Market Cap34.626 M
P/E-4.0x
Yield0.0%
HealthFair
NYSE
Oragenics Inc (OGEN)
Fair Value45.6% Upside
Undervalued
Market Cap2.482 M
P/E-0.2x
Yield0.0%
HealthFair
NYSE
Adc Therapeutics SA (ADCT)
Fair Value18.3% Upside
Undervalued
Analyst367.3% Upside
Market Cap139.9 M
P/E-1.0x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
Aeon Biopharma Inc (AEON)
Fair Value12.8% Upside
Fair
Market Cap7.787 M
P/E-0.1x
Yield0.0%
HealthFair
NYSE
Annovis Bio Inc (ANVS)
Fair Value-3.5% Downside
Fair
Analyst488.2% Upside
Market Cap79.553 M
P/E-1.9x
Yield0.0%
HealthWeak
NYSE
Featured in
High-Beta Stocks
Serina Therapeutics Inc (SER)
Fair Value12.6% Upside
Fair
Analyst326.0% Upside
Market Cap32.095 M
P/E-1.6x
Yield0.0%
HealthWeak
NYSE
AIM ImmunoTech Inc (AIM)
Fair Value14.5% Upside
Fair
Market Cap5.808 M
P/E-0.5x
Yield0.0%
HealthWeak
NYSE
Azitra Inc (AZTR)
Fair Value33.2% Upside
Undervalued
Analyst457.6% Upside
Market Cap2.233 M
P/E-0.2x
Yield0.0%
HealthWeak
NYSE
Calidi Biotherapeutics Inc (CLDI)
Fair Value33.0% Upside
Undervalued
Market Cap2.299 M
P/E-0.1x
Yield0.0%
HealthWeak
NYSE
Evommune Inc (EVMN)
Fair Value-6.4% Downside
Fair
Analyst139.2% Upside
Market Cap472.2 M
P/E-6.2x
Yield0.0%
HealthFair
NYSE
Featured in
Small-Cap Stocks
Kairos Pharma Ltd (KAPA)
Fair Value7.5% Upside
Fair
Market Cap6.963 M
P/E-1.2x
Yield0.0%
HealthWeak
NYSE
Maia Biotechnology Inc (MAIA)
Fair Value-6.2% Downside
Fair
Analyst766.8% Upside
Market Cap82.689 M
P/E-3.5x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
OS Therapies Inc (OSTX)
Fair Value-1.7% Downside
Fair
Analyst457.4% Upside
Market Cap72.597 M
P/E-2.0x
Yield0.0%
HealthWeak
NYSE
Pelthos Therapeutics Inc (PTHS)
Fair Value16.3% Upside
Fair
Analyst102.2% Upside
Market Cap92.8 M
P/E-1.9x
Yield0.0%
HealthFair
NYSE
Featured in
High-Beta Stocks
High-Beta Momentum
Regentis Biomaterials Ltd (RGNT)
Fair Value-13.3% Downside
Fair
Analyst383.1% Upside
Market Cap10.67 M
P/E-0.8x
Yield0.0%
HealthWeak
NYSE
